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Abstract: Post-hemorrhagic ventricular dilatation (PHVD) is characterized by a build-up of cerebral
spinal fluid (CSF) in the ventricles, which increases intracranial pressure and compresses brain
tissue. Clinical interventions (i.e., ventricular taps, VT) work to mitigate these complications through
CSF drainage; however, the timing of these procedures remains imprecise. This study presents
Neonatal NeuroMonitor (NNeMo), a portable optical device that combines broadband near-infrared
spectroscopy (B-NIRS) and diffuse correlation spectroscopy (DCS) to provide simultaneous
assessments of cerebral blood flow (CBF), tissue saturation (StO2), and the oxidation state of
cytochrome c oxidase (oxCCO). In this study, NNeMo was used to monitor cerebral hemodynamics
and metabolism in PHVD patients selected for a VT. Across multiple VTs in four patients, no significant
changes were found in any of the three parameters: CBF increased by 14.6 ± 37.6% (p = 0.09), StO2 by
1.9 ± 4.9% (p = 0.2), and oxCCO by 0.4 ± 0.6 µM (p = 0.09). However, removing outliers resulted
in significant, but small, increases in CBF (6.0 ± 7.7%) and oxCCO (0.1 ± 0.1 µM). The results of
this study demonstrate NNeMo’s ability to provide safe, non-invasive measurements of cerebral
perfusion and metabolism for neuromonitoring applications in the neonatal intensive care unit.
Keywords: near-infrared spectroscopy; diffuse correlation spectroscopy; premature brain injury;
hydrocephalus; intraventricular hemorrhaging; ventricular tap; neuromonitoring; cerebral blood flow;
metabolism; cytochrome c oxidase
1. Introduction
Premature birth, defined as a gestational period less than 37 weeks, occurs in 8% of infants in
Canada [1]. Those born with lower birthweights (<1500 g) are at an increased risk of neurological
complications, including deficits in cognition and behaviour as well as a higher incidence of major motor
disorders (e.g., cerebral palsy) [2]. The largest contributor to preterm brain injury is intraventricular
hemorrhaging (IVH). The pathogenesis of IVH involves the combination of an immature cerebral
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vascular anatomy (i.e., a highly vascularized germinal matrix) and poor cerebral blood flow (CBF)
regulation [3,4]. It is believed that IVH elicits an inflammatory response, followed by fibrosis and
subsequent obstruction of cerebral spinal fluid (CSF) drainage [5]. This can lead to accumulation of
CSF, increased intracranial pressure (ICP), and dilatation of the entire ventricular system, referred to as
post-hemorrhagic ventricular dilatation (PHVD).
PHVD is a major complication in severe cases of IVH (Grade III and higher), where more
than 50% of the lateral ventricles are experiencing a bleed [6,7]. Due to a progressively increasing
ICP, any delay in treatment can result in white matter atrophy and neurologic deterioration [4,8].
Cranial ultrasound (cUS) is the current gold standard in diagnosing and monitoring the progression
of PHVD through ventricular measurements such as the ventricular index (VI), anterior horn width
(AHW), and thalamo-occipital distance (TOD) [9]. Given these measures, there is still some debate
over the timing of clinical intervention [10]. An early approach used by many European centres relies
on ventricular measurements before patients are symptomatic. Intervention consists of a variety
of techniques to drain CSF, including external ventricular drains (EVD), lumbar punctures (LP),
and ventricular taps (VT), among others. [11]. In comparison, many North American centres employ a
later approach where treatment is initiated depending on the ventricular index and clinical signs (e.g.,
increased ICP, head circumference, ventricle size, tense fontanelle, etc.) [12,13]; similar techniques are
then implemented to drain CSF.
The discrepancy in the timing of clinical intervention is largely due to a lack of adequate
monitoring techniques to quantify PHVD progression and treatment efficacy. Recent work has
elucidated the benefits of hemodynamic and metabolic neuromonitoring surrounding the development
of PHVD [14,15]. These metrics have shown potential to act as prognostic markers of PHVD symptoms
and could better indicate when to implement CSF drainage strategies. Measurements of CBF by
transcranial doppler (TCD) have proven robust in premature infants; however, continuous monitoring
is not ideal as TCD is operator-dependent and only measures macrovascular changes in blood
flow [16,17]. Biomedical optics instead provide a safe, non-invasive technique ideal for longitudinal
brain monitoring at the bedside [3,18–20].
This study presents an in-house built brain monitoring system referred to as NNeMo (Neonatal
NeuroMonitor) that is capable of simultaneous measurement of cerebral perfusion, tissue saturation,
and oxygen metabolism at the bedside through combining two optical techniques. Broadband
near-infrared spectroscopy (B-NIRS) uses near-infrared light to measure absorption properties of tissue
that can be used to estimate the concentrations of oxy and deoxyhemoglobin, from which the cerebral
tissue saturation (StO2) can be calculated [21]. B-NIRS can also provide a direct measurement of
cerebral metabolism by monitoring absorption changes in the oxidation state of cytochrome c oxidase
(oxCCO), which is directly related to mitochondrial ATP production in the electron transport chain [22].
Diffuse correlation spectroscopy (DCS) is an emerging technique that provides continuous monitoring
of CBF by analyzing dynamic light scatter from red blood cells [23]. DCS has been validated against
multiple modalities, including dynamic contrast-enhanced NIRS, Positron Emission Tomography with
oxygen-15 (15O) labelled water, and Arterial spin labelling MRI [24–26]. NNeMo combines B-NIRS
and DCS technology to simultaneously monitor CBF, StO2, and oxCCO.
This study presents the clinical translation of NNeMo to monitor PHVD infants in the neonatal
intensive care unit (NICU) undergoing CSF drainage via ventricular taps. Previous work using
contrast-enhanced NIRS reported a small increase in CBF after the VT, but with no concurrent change
in cerebral energy metabolism [14]. However, only single time-point measurements before and after
the procedure were acquired due to the need to inject a contrast agent (indocyanine green). Here,
we present continuous bedside monitoring of cerebral perfusion and metabolism in PHVD patients
undergoing a VT, with the goal of assessing any potential treatment-related changes in CBF and
oxCCO. Based on the magnitude of CBF changes previously reported [14], it was hypothesized that
CSF drainage would lead to a modest increase in CBF, but with minimal impact on oxCCO.
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2. Materials and Methods
2.1. Patient Population
This study was approved by the Western University Health Sciences Research Ethics Board
(Project Identification Code: 17828), which adheres to the guidelines of the Canadian Tri-Council Policy
Statement: Ethical Conduct for Research Involving Humans. Patients with PHVD were enrolled after
obtaining parental consent. The initial IVH was diagnosed by cranial ultrasound (cUS) and graded
according to the Papile scale [5]. The decision to perform a ventricular tap was based on standard of
care, including clinical evidence (apnea, bradycardia, full fontanelles) and increased ventricle size as
measured by cUS.
2.2. Study Design
Infants receiving a VT were monitored throughout the procedure with NNeMo (Figure 1a). Prior to
surgical setup, optical probes were placed on the infant’s scalp above the frontoparietal cortex and held
in place by a custom-built probe holder (Figure 1b). Two optical probes (one for the B-NIRS and one
for the DCS) delivered light to the scalp. Source power levels were maintained within ANSI standards
for skin exposure. A common detection fiber bundle was used to collect diffusely reflected light that
had propagated through the head. The DCS and B-NIRS systems collected light at source-detector
distances (SDD) of 2 and 3 cm, respectively, to ensure adequate brain interrogation (Figure 1c). As an
additional precaution, a phototherapy eye shield was employed to avoid exposing the subject’s eyes to
the light sources.
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Figure 1. (a) Neonatal NeuroMonitor (NNeMo) combining broadband near-infrared spectroscopy (B-
NIRS) and diffuse correlation spectroscopy (DCS) techniques. (b) Optical fibers affixed to an infant’s 
head using a 3D-printed probe holder. A phototherapy eye shield was used as a safety precaution. (c) 
Optical fiber schematic showing two optical sources and a common detection fiber (SDD: DCS 2 cm; 
B-NIRS 3 cm). 
Figure 1. (a) Neonatal NeuroMonitor (NNeMo) combining broadband near-infrared spectroscopy
(B-NIRS) and diffuse correlation spectroscopy (DCS) techniques. (b) Optical fibers affixed to an infant’s
head using a 3D-printed probe holder. A phototherapy eye shield was used as a safety precaution.
(c) Optical fiber schematic showing two optical sources and a common detection fiber (SDD: DCS 2 cm;
B-NIRS 3 cm).
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Following sterilization of the surgical site, a VT was performed by a pediatric neurosurgeon.
A needle was inserted into the lateral ventricles (Figure 2a) to allow for CSF drainage (Figure 2b).
Following sufficient CSF removal, as determined by the clinician, the needle was removed and gentle
pressure was applied to the needle insertion site. Optical data were collected throughout the VT,
extending a minimum of 10 min prior to and following the procedure. B-NIRS and DCS data were
acquired sequentially at a sampling rate of 250 ms and each dataset was averaged to achieve a final
temporal resolution of 7 s.
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Figure 2. (a) Pediatric neurosurgeon inserting a needle into the ventricle and (b) draining cerebral 
spinal fluid (CSF) from the patient. Optical probes were affixed to the patient’s head throughout the 
procedure. 
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2.3. Instrumentation
NNe o was constructed by combining B-NIRS and DCS modalities using a multiplexing shutter
system controlled by custom software developed in LabView (2017 SP1, National Instruments, Austin,
TX, USA) and MATLAB (R2018b, MathWorks, Natick, MI, USA) [27]. The acquisition times of both the
B-NIRS and DCS were set to 250 ms (4 Hz). The shutter system cycled between the two subsystems in
3-s intervals. A total of 12 data points were acquired in each interval and averaged for both B-NIRS and
DCS measurements. A 0.5-s delay was added between the intervals to account for shutter transition
times and to avoid overlap between the B-NIRS and DCS data.
The B-NIRS light source was a 20-W halogen bulb (Hl-2000-HP, Ocean Optics, Delay Beach, FL,
USA) that was filtered from 600 to 1000 nm and coupled into a custom optical fiber bundle (2.4 mm
diameter, 30 µM core, 0.55 numerical aperture ((NA), Loptek, Berlin, Germany) that directed the light
to the head. Light from the interrogated tissue was collected by 3 fiber bundles (2 mm diameter,
30 µm core, 0.55 NA, Loptek, Berlin, Germany) that were linearly aligned at the entrance of the
spectrometer (iDus 420, Andor, Oxford Instruments, Abingdon, UK; 548–1085 nm bandwidth; 1.65 nm
resolution; P&P Optica, Waterloo, ON, Canada). For DCS, light from a long coherence laser (DL785-100s,
CrystaLaser, Reno, NV, USA) was coupled into a fiber bundle (4 × 200 µ core diameter, 0.22 NA,
Loptek, Berlin, Germany) and directed towards the head. Light was collected by 4 single-mode fibers
(8 µ core diameter, 0.12 NA, Loptek, Berlin, Germany) and coupled to a four-channel single photon
counting module (SPCM-AQR-15-FC, Excelitas Technologies, Montreal, QC, Canada). The output from
each detector was fed into an edge-detecting counter on a PCIe-6612 counter/timer data acquisition
board (National Instruments) [28]. Photon counts were recorded and processed using in-house
developed software (LabVIEW, MATLAB) [29]. For each detector, the software generated intensity
autocorrelation curves at 50 delay times ranging from 1 µs to 1 ms.
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For use in the NICU, the optical fibers were designed to be lightweight and flexible, with a 90◦
bend at the patient end to further minimize weight on the infant. A 3D-printed fiber probe holder
(5 × 2 × 1 cm; Flexible Resin, Form 2, Formlabs, Somerville, MA, USA) was designed to secure the
three optical probes (2 emission, 1 detection) to the patient’s forehead using a soft and flexible base
material with a non-abrasive strap (Figure 1b).
2.4. Data Processing
2.4.1. NIRS Analysis: Quantifying StO2 and Changes in oxCCO Concentration
Prior to clinical measurements, a reference spectrum was acquired using a pinhole attenuator to
characterize the spectral properties of the optical system. In addition, a measurement of the dark noise
was acquired to characterize ambient light conditions. For the clinical NIRS data, each reflectance




re f erenceλ − darkλ
)
, (1)
where spectrumλ refers to the clinical measurement at wavelength λ.
To quantify chromophore concentrations, while accounting for the contribution of light scatter,
a derivative approach was utilized [18,30,31]. First and second derivatives of R(λ) were calculated
and fit to the solution of the diffusion approximation for a semi-infinite homogeneous medium [19].
Light absorption (Equation (2)) and scattering (Equation (3)) parameters were input into the solution
as follows [30]:
µa(λ) = WF·εH2O(λ) + Hb
b
·εHb(λ) + HbOb2·εHbO2(λ), (2)
where WF is the tissue water fraction, Hbb and HbO2b are baseline concentrations of deoxyhemoglobin








where α is the scattering power and A is the µs’ value at λ = 800 nm. Reflectance spectra measured at
baseline were analyzed with a multi-parameter fitting algorithm based on a constrained least-square
minimization using a custom MATLAB function (fminsearchbnd). Briefly, second derivative R(λ)
spectra were fit by the model between 815 and 845 nm to obtain WF. The WF value was incorporated
into the second derivative fit from 680 to 800 nm to determine Hbb. Lastly, WF and Hbb were used in
the analysis of the first derivative spectrum. The fitting procedure extended from 680 to 845 nm to
obtain an estimate of HbO2b [30].
Following baseline analysis, a modified Beer–Lambert law based on the UCLn algorithm
(Equation (4)) was used to calculate changes in hemoglobin and oxCCO concentrations for the




















where ∆HbO2, ∆Hb, and ∆oxCCO are relative changes from baseline in oxy-hemoglobin,
deoxy-hemoglobin, and the oxidation state of cytochrome c oxidase. The differential pathlength
(DP) was set to 4.39 based on previous literature [32,33] and corrected for the wavelength dependency
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of the pathlength [34]. ∆A represents the measured change in attenuation. Relative and baseline









2.4.2. DCS Analysis: Relative Measure of CBF
Acquired normalized intensity autocorrelation data were converted to electric field autocorrelation
data following the Siegert relation [35,36]:




where g2(ρ,τ) is the measured normalized intensity autocorrelation, β is the coherence factor, G1(ρ,τ) is
the electric field autocorrelation function, and <I(ρ,τ)> is the averaged detected intensity. The parameter
ρ refers to the SDD and τ is the correlation time. G1 was modeled using the solution to the diffusion
approximation for a semi-infinite homogenous medium and assuming the motion of light scatterers
can be characterized by a pseudo-Brownian motion [35,37,38]. Fitting was conducted for ρ = 2 cm
and using the dynamic µa measurements obtained by B-NIRS. A constant value for µs’ of 8 cm−1 was
used in accordance with recent literature [39]. Fitting each autocorrelation curve provided an index of
cerebral blood flow (CBFi).
2.5. Statistical Analysis
All data are presented as mean ± standard deviation (range) unless otherwise noted. Since the
tapping duration varied between procedures, the perfusion, oxygen saturation, and metabolic data
collected for each VT were temporally normalized to the average tap duration to obtain mean time
courses. For pre- and post-VT statistics, data were limited to two minutes prior to needle insertion
and following needle removal to avoid motion artifacts. To assess the overall change in CBFi, StO2,
and oxCCO due to a VT, a one-tailed paired t-test was used to compare pre- and post-VT measurements.
Potential outliers were identified as points greater than q3 + w× (q3− q1) or less than q1 −w × (q3 − q1)
in the box plots, where w represents the whisker length and q indicates the quartile number. Statistics
were repeated excluding any outliers. A matched pairs power analysis was conducted using the
G*Power 3 software (v3.1.9.7, Düsseldorf, Germany) to calculate the total sample size required to
achieve significance [40]. Statistical significance was based on a p-value < 0.05; power was set to 0.8.
3. Results
Optical measurements were acquired during 14 ventricular taps across four patients (one female,
three males, gestational age 25.0 to 37.6 weeks, mean = 29.2 ± 5.6 weeks). Data from four events
were excluded due to excessive patient motion. A further three B-NIRS datasets were excluded due
to ambient light contamination. DCS data acquired during these periods were not impacted and
remained in the analysis. A total of 10 ventricular taps were analyzed for CBFi, and seven for StO2 and
oxCCO. Clinical parameters are displayed in Table 1.
Infants were monitored continuously throughout the ventricular tap, spanning needle insertion
and CSF drainage. Ventricular tap duration varied across the interventions with an average duration
of 16.1 ± 7.7 min (range: 8.75 to 29.25 min). Average time courses of CBFi, StO2, and oxCCO during
the tapping procedure are displayed in Figure 3.
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Table 1. Clinical parameters for post-hemorrhagic ventricular dilatation (PHDV) patients.
Gestational age at birth (weeks) 29.2 ± 5.6 (25–37 4/7)
Birth weight (g) 1259.0 ± 746.7 (810–2376)
Sex (n) F = 1, M = 3
Apgar 1 min 3.8 (1–8)
Number of VT performed (n) 7.8 (5–10)
Age at first VT (weeks) 3.8 ± 2.1 (2.3–7)
EVD (n) 2
VP shunt (n) 3
IVH Grade: Bilateral III 2
IVH Grade: III (R)/ IV (L) 1
IVH Grade: Bilateral IV 1
EVD, external ventricular drain; VP ventriculoperitoneal; IVH, intraventricular hemorrhage.
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Figure 3. Change in cerebral blood flow index (∆CBFi, n = 10), tissue saturation (StO2, n = 7),
and change in oxidation state of cytochrome c oxidase (∆oxCCO, n = 7) averaged across ultiple trials
over the course of ventricular taps (VT). Data were temporally normalized to the averaged tap duration
(16 min) and aligned to VT start and end points. Each time course is displayed with its standard error
(shaded background).
The grey shaded regions in Figure 3 surrounding the CSF drainage period represent the intervals
used to calculate average pre- and post-VT values. Figure 4 presents the changes in CBFi and oxCCO
relative to baseline and pre- and post-VT StO2 values. The outliers indicated on the plot borders
corresponded to ∆CBFi changes of 122.0% and −25.0%, and ∆oxCCO of 1.7 µM. Averaged values are
displayed in Table 2 along with t-test and power analysis results. Significance was not met for any
of the parameters. Power analysis indicated that sample sizes of 29 and 18 for ∆CBFi and ∆oxCCO,
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respectively, would be required to achieve significance. A significant increase was found for both
∆CBFi and ∆oxCCO if outliers were excluded.Brain Sci. 2020, 10, x FOR PEER REVIEW 8 of 13 
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that were averaged over 2-min periods. Individual data points are displayed; outliers are indicated by
the crosses on the borders and represent ∆CBFi values of 122% and −25% and ∆oxCCO of 1.7 µM.
Table 2. Average changes following VT relative to baseline, t-test, and power analysis.
Statistical Parameter ∆CBFi (%) ∆StO2 (%) ∆oxCCO (µM)
Average change 14.6 ± 37.6 1.9 ± 4.9 0.4 ± 0.6
p-value 0.09 0.20 0.09
Required sample size for significance 1 29 45 18
Average change excluding outliers 6.0 ± 7.7 - 0.1 ± 0.1
p-value excluding outliers 0.05 - 0.02
1 Power analysis with G*Power 3 [40], (Power = 0.8; error probability 0.05).
4. Discussion
The purpose of this study was to implement the recently developed Neonatal NeuroMonitor
(NNeMo) to assess cerebral hemodynamics and metabolism during ventricular taps in patients with
post-hemorrhagic ventricular dilatation. Compared with commercial NIRS devices that focus on
monitoring StO2, the goal of implementing NNeMo was to assess the direct impact of a VT on CBF,
as measured by DCS, and cerebral oxygen metabolism, as determined by monitoring oxCCO with
B-NIRS. Both methods provide continuous recordings, which enabled CBFi and oxCCO to be monitored
throughout the tapping procedure (Figure 3).
In hydrocephalus, decreases in cerebral perfusion are expected to precede changes in metabolism
and clinical symptoms [41]. In agreement with this concept, reductions in CBF have been shown
to impact metabolism only when CBF drops below a certain threshold [27,42]. During a VT, as the
ventricle volume and ICP decrease, perfusion is expected to improve. The possibility of concurrent
changes in metabolism would therefore depend on the extent to which CBF is improved by the VT.
A large increase in oxCCO following a VT would suggest that the mitochondria were oxygen-limited
prior to the procedure, implying that the intervention could have been performed earlier [43]. In this
study, it was anticipated that a VT would improve CBF, but the magnitude of the perfusion increase
would likely not be sufficient to have an effect on oxCCO. Following 10 VTs, a non-significant increase
was found in ∆CBFi (14.6 ± 37.6%, p = 0.09) and ∆oxCCO (0.4 ± 0.6 µM, p = 0.09), while little change
was observed in ∆StO2 (1.9 ± 4.9%, p = 0.2). Power analysis indicated that achieving significance
for these relatively small increases would require a sample size of 29 for ∆CBFi and 18 for ∆oxCCO.
Removing the outliers in the ∆CBFi (n = 2) and ∆oxCCO (n = 1) datasets did result in significant
Brain Sci. 2020, 10, 452 9 of 13
increases in both parameters; however, the average changes remained small (6.0 ± 7.7% for ∆CBFi and
0.1 ± 0.1 µM for ∆oxCCO).
Several studies have investigated the potential impact of CSF drainage on cerebral hemodynamics
in PHVD patients. An increase in CBF velocity was found by Doppler ultrasound across seven
patients [44], and stable oxCCO, as measured by NIRS, in 23 infants receiving a VT or lumbar puncture
(LP) [45]. In an earlier study, Casaer et al. reported that oxCCO increased in infants with grade
3 or 4 IVH who received an LP if patients had clinical signs of elevated ICP (i.e., increased head
circumference, bulged fontanel, n = 4), but not if these symptoms were absent (n = 4) [46,47]. Similarly,
elevated cerebral oxygenation has been reported during cerebrospinal fluid removal, which was
interpreted as evidence of increased CBF [45,48,49]. Previous work by our group measured absolute
CBF and the cerebral metabolic rate of oxygen (CMRO2) before and following a VT using dynamic
contrast-enhanced NIRS [14]. A significant increase in CBF (15.6%) across 20 VTs was found with no
change in CMRO2. In general, evidence of increased CBF following CSF removal has been consistent
across studies. The lack of a metabolic response can be explained by the modest perfusion increase,
indicating that the reduction in CBF prior to the VT was not sufficient to impede oxygen delivery [18,31].
The results of the current study complement these findings as the average increases in CBFi and
oxCCO were small and only reached significance after removing outliers. It is important to note that
the technologies used across studies to monitor cerebral perfusion and oxygen metabolism are quite
different, yet the findings are similar.
Compared with McLachlan et al. [14], the use of the hybrid B-NIRS/DCS system had the
advantages of not requiring an injection of an exogenous contrast agent to assess cerebral perfusion
and metabolism and providing continuous monitoring of these parameters throughout the tapping
procedure. The combination of B-NIRS and DCS in NNeMo was achieved using a multiplexing shutter
system to prevent crosstalk between the two techniques. The intensity of the light from the DCS laser
is large enough to easily saturate the B-NIRS spectrometer, which impedes its ability to detect the
relatively small spectral features of oxCCO. Conversely, broadband light from the B-NIRS light source
is highly incoherent, which can degrade the temporal correlation of dynamic light scattering used by
DCS to measure CBFi [50]. These issues can be overcome by cycling data acquisition between the two
techniques. In this study, a sample rate of 4 Hz for both systems with an overall cycling time of 7 s
was considered sufficient, given the procedure was between 10 to 30 min in duration. It should be
noted, however, that the multiplexing shutter system has the flexibility to achieve higher temporal
resolutions if required. Both systems are capable of sampling rates up to 10 Hz, which could be
used for instance to capture blood flow pulsatility [28]. The minimum cycling time would be on the
order of 300 ms, accounting for shutter opening and closing times of less than 50 ms [51]. Alternately,
truly simultaneous measurements could be achieved using optical filters to selectively block B-NIRS
and DCS light sources from the opposing detectors. Recent works describing hybrid B-NIRS/DCS and
time-resolved NIRS/DCS systems utilizing bandpass and notch filters have been proposed [50,52,53].
In this clinical application, the two major sources of signal contamination were motion artifacts
and ambient light. Maintaining adequate probe contact with the scalp was challenging on infants
with PHVD as the head is distended due to the enlarged ventricles. As CSF is drained during a VT,
head circumference decreases, which can loosen the straps holding the probes to the head. To mitigate
this issue, the probes were placed on the forehead above the frontoparietal cortex, where there is
minimal change in head circumference. In addition, the elastic property of the strap used to hold the
probes in place helped maintain good contact throughout the procedure. To minimize motion artifacts,
an NICU nurse gently restrained the patient’s head during the VT. Other sources of motion were the
repositioning of the infant in the cot for needle insertion and the application of pressure to the head
after the needle was retracted (Figure 2). As a result, data analysis was limited to 2-min windows
immediately prior to and following the VT. This short period prevented monitoring for possible
long-term changes after the VT, despite NNeMo’s measurement stability over extended durations [27].
In three experiments, subjects were located in an environment with excessive ambient light, as reflected
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by greater dark count measurements acquired by B-NIRS. Since oxCCO only contributes approximately
10% of the total spectral signal [22], it was necessary to remove B-NIRS datasets in which the dark
count was deemed excessive. In contrast, ambient light did not have the same impact on the DCS
measurements due to the stronger intensity of the laser and therefore these datasets were included in
the analysis.
Another potential source of error with optical neuromonitoring methods is the effect of scalp
contamination. The influence of the scalp is considerably less in infants compared with adults,
and within this study its effects were mitigated using appropriate source-detector distances for B-NIRS
(SDD = 3 cm) and DCS (SDD = 2 cm) [54]. An additional source of signal contamination unique to
hydrocephalus is possible light loss in the enlarged ventricle as the cortical mantle becomes increasingly
thin. Our group demonstrated that this effect could distort absorption spectra as the thickness of
the cortical mantle approaches 1 cm [14]. This likely did not have a significant effect on the CBFi
measurements since the SDD was 2 cm. The NIRS spectra were, however, acquired with SDD = 3 cm,
which would increase the chance of light loss in the ventricles. The excellent agreement in mean
baseline StO2 values from the current and previous study—58.4 ± 9.7% compared to 58.9 ± 2.7% from
reference [14]—indicates that cortical thickness did not have a significant effect.
Future work will investigate a potential correlation of hemodynamic changes with subsequent
markers of brain injury. Comparison to clinical outcomes has the potential to establish clinical
thresholds of perfusion/metabolic change and could aid in describing VT efficacy or in gauging brain
injury severity during the progression of PHVD.
5. Conclusions
In summary, this feasibility study presents an optical system capable of providing real-time
monitoring of cerebral perfusion and oxygen metabolism in the NICU. In this application, cerebral
blood flow and metabolic changes monitored throughout VTs were small and only reached significance
after removing outliers. These results are in good agreement with previous studies. Considering that
the hybrid optical system is portable and completely non-invasive, it is well suited for neuromonitoring
in PHVD patients who may be suspected of larger cerebral hemodynamic changes based on
clinical symptoms.
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